Vivimed Labs Limited Share Price and Company Fundamentals
Last traded: Today at 9:57 AM
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates through two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India.
Key Metrics
PE ratio
-
PB ratio
-
Dividend yield
-
Beta
0.50
Market cap
₹588.69M
Enterprise value
₹4.42B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 586 |
| Website | https://www.vivimedlabs.com |
| Mailing address | 6-3-866/1/G 1, GMR Towers 3rd Floor Greenlands, Begumpet Hyderabad 500016 India |
| Phone / Fax | 91 40 6608 6608 / 91 40 6608 6699 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Vivimed Labs Limited paid ₹- dividend and the ex-dividend date was 19 Sep 2018.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.VIVIMEDLAB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Mar 2026, following are the company executives and directors listed on Vivimed Labs Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Dr. Manohar Rao Varalwar | Whole Time Chairman | 89 | |
| Mr. Santosh Varalwar | MD & Executive Director | 63 | |
| Mr. Yugandhar Kopparthi | Compliance Officer & Company Secretary | ||
| Mr. Sandeep Varalwar B.Pharma | Whole Time Director | 57 |
Profitability and management effectiveness
Profit margin
-22.36%
Operating margin
-27.12%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Vivimed Labs Limited is 588.69M and its enterprise value is 4.42B. The enterprise value to revenue ratio of VIVIMEDLAB is 4.05. The enterprise value to EBITDA ratio of VIVIMEDLAB is 193.83.
The VIVIMEDLAB's stocks Beta value is 0.50 making it 50% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Vivimed Labs Limited (NSE:VIVIMEDLAB) Frequently Asked Questions
1. What is Vivimed Labs Limited's Stock Symbol?
Vivimed Labs Limited trades on NSE under the ticker symbol "VIVIMEDLAB".
2. What is Vivimed Labs Limited's stock price today?
One share of VIVIMEDLAB stock can currently be purchased for approximately ₹7.1.
3. How can I contact Vivimed Labs Limited?
Vivimed Labs Limited's mailing address is 6-3-866/1/G 1, GMR Towers 3rd Floor Greenlands, Begumpet Hyderabad 500016 India. The company can be reached via phone at 91 40 6608 6608.
4. What is Vivimed Labs Limited's official website?
The official website of Vivimed Labs Limited is https://www.vivimedlabs.com.